cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.5498062
title: NOAA MLOST version 3.5.3

description: PLEASE SEE NOAA LICENCE, USE AND REFERENCE REQUIREMENTS AT:<br> https://psl.noaa.gov/data/gridded/data.mlost.html<br> This is NOAA MLOST version 3.5.3 uploaded to Zenodo with permission.<br> No additional guarantees or requirements are added, follow those of NOAA listed in above link. As of 2021-09-14, this dataset's latest version is now NOAAGlobalTemp v5; https://www.ncei.noaa.gov/products/land-based-station/noaa-global-temp Publication date listed as 2008-05-15 to coincide with publication of the description paper: https://journals.ametsoc.org/view/journals/clim/21/10/2007jcli2100.1.xml
DOI: 10.5281/zenodo.5498061
title: NOAA MLOST version 3.5.3

description: PLEASE SEE NOAA LICENCE, USE AND REFERENCE REQUIREMENTS AT:<br> https://psl.noaa.gov/data/gridded/data.mlost.html<br> This is NOAA MLOST version 3.5.3 uploaded to Zenodo with permission.<br> No additional guarantees or requirements are added, follow those of NOAA listed in above link. As of 2021-09-14, this dataset's latest version is now NOAAGlobalTemp v5; https://www.ncei.noaa.gov/products/land-based-station/noaa-global-temp Publication date listed as 2008-05-15 to coincide with publication of the description paper: https://journals.ametsoc.org/view/journals/clim/21/10/2007jcli2100.1.xml
DOI: 10.5281/zenodo.3346050
title: PERCEIVE: WP1: Framework for comparative analysis of the perception of Cohesion Policy and identification with the European Union at citizen level in different European countries: Survey at citizen level and data relative to regional performance of the Cohesion Policy and institutional quality

description: 1. Orignal PERCEIVE survey data (STATA file) 2. description of survey questions, descriptive results (word file) 3. EU Deliverable document with descriptive analysis of survey questions ***please cite the following when using the microdata: Bauhr, M., & Charron, N. (2020). The EU as a savior and a saint? Corruption and public support for redistribution. <em>Journal of European Public Policy</em>, <em>27</em>(4), 509-527. https://www.tandfonline.com/doi/full/10.1080/13501763.2019.1578816
description: Dataset limited to PERCEIVE members only until end of embargo time
DOI: 10.5281/zenodo.845348
title: PERCEIVE: WP1: Framework for comparative analysis of the perception of Cohesion Policy and identification with the European Union at citizen level in different European countries: Survey at citizen level and data relative to regional performance of the Cohesion Policy and institutional quality

description: 1. Orignal PERCEIVE survey data (STATA file) 2. description of survey questions, descriptive results (word file) 3. EU Deliverable document with descriptive analysis of survey questions ***please cite the following when using the microdata: Bauhr, M., & Charron, N. (2020). The EU as a savior and a saint? Corruption and public support for redistribution. <em>Journal of European Public Policy</em>, <em>27</em>(4), 509-527. https://www.tandfonline.com/doi/full/10.1080/13501763.2019.1578816
description: Dataset limited to PERCEIVE members only until end of embargo time
DOI: 10.34740/kaggle/dsv/2614185
title: YouTube Trending Video Dataset (updated daily)
DOI: 10.5281/zenodo.5506699
title: Dataset related to article: "Therapist Driven Rehabilitation Protocol for Patients with Chronic Heart and Lung Diseases: A Real-Life Study"

description: We provide the raw data used for the following article: Simonelli C, Vitacca M, Ambrosino N, Scalvini S, Rivadossi F, Saleri M, Fokom AG, Speltoni I, Ghirardi R, Paneroni M.<br> <em>Therapist Driven Rehabilitation Protocol for Patients with Chronic Heart and Lung Diseases: A Real-Life Study</em>.<br> "Int J Environ Res Public Health". 2020 Feb 5;17(3):1016. doi: 10.3390/ijerph17031016. PMID: 32033505; PMCID: PMC7037983. <br> <strong>Abstract</strong><br> Therapist driven protocols may help to tailor rehabilitation programs to individual patients. We aimed to test the feasibility, safety, and clinical usefulness of a therapist driven protocol for rehabilitation including exercise training of patients with heart or lung diseases. An internal audit elaborated the Cardio-Respiratory Exercise Maugeri Algorithm (CREMA) based on: (a) standardized baseline assessments, (b) decision-making pathways, and (c) frequency/intensity/time/type (FITT) of prescription for each exercise. Outpatients (<em>n</em> = 620) with chronic heart disease (CHD), recent myocardial revascularization (REVASC), chronic airway (Obstructive), and restrictive lung (Restrictive) diseases underwent exercise training according to CREMA during 4 years. Peripheral muscle strengthening was the most prescribed exercise (83.6%), while arm endurance training was the least frequently (0.75%). Exercise prescription varied widely among the disease groups (interval training 19-47%, balance 35-49%, lower limb muscle training 6-15%). After training, REVASC patients were the best improvers in the 6 min walking distance (+48.7 (56.1) m), maximal inspiratory pressure (+9.6 (15.4) cmH<sub>2</sub>O), and daily steps (+1087.2 (3297.1) n/day). Quadriceps and biceps strength, maximal expiratory pressure, and balance improved in all groups, without significant differences. Minor side effects were observed in 11.2% of the patients. The CREMA therapist driven protocol was feasible, safe, and useful for prescribing tailored training programs. Exercise prescriptions and training response differed among diseases.
DOI: 10.5281/zenodo.5506698
title: Dataset related to article: "Therapist Driven Rehabilitation Protocol for Patients with Chronic Heart and Lung Diseases: A Real-Life Study"

description: We provide the raw data used for the following article: Simonelli C, Vitacca M, Ambrosino N, Scalvini S, Rivadossi F, Saleri M, Fokom AG, Speltoni I, Ghirardi R, Paneroni M.<br> <em>Therapist Driven Rehabilitation Protocol for Patients with Chronic Heart and Lung Diseases: A Real-Life Study</em>.<br> "Int J Environ Res Public Health". 2020 Feb 5;17(3):1016. doi: 10.3390/ijerph17031016. PMID: 32033505; PMCID: PMC7037983. <br> <strong>Abstract</strong><br> Therapist driven protocols may help to tailor rehabilitation programs to individual patients. We aimed to test the feasibility, safety, and clinical usefulness of a therapist driven protocol for rehabilitation including exercise training of patients with heart or lung diseases. An internal audit elaborated the Cardio-Respiratory Exercise Maugeri Algorithm (CREMA) based on: (a) standardized baseline assessments, (b) decision-making pathways, and (c) frequency/intensity/time/type (FITT) of prescription for each exercise. Outpatients (<em>n</em> = 620) with chronic heart disease (CHD), recent myocardial revascularization (REVASC), chronic airway (Obstructive), and restrictive lung (Restrictive) diseases underwent exercise training according to CREMA during 4 years. Peripheral muscle strengthening was the most prescribed exercise (83.6%), while arm endurance training was the least frequently (0.75%). Exercise prescription varied widely among the disease groups (interval training 19-47%, balance 35-49%, lower limb muscle training 6-15%). After training, REVASC patients were the best improvers in the 6 min walking distance (+48.7 (56.1) m), maximal inspiratory pressure (+9.6 (15.4) cmH<sub>2</sub>O), and daily steps (+1087.2 (3297.1) n/day). Quadriceps and biceps strength, maximal expiratory pressure, and balance improved in all groups, without significant differences. Minor side effects were observed in 11.2% of the patients. The CREMA therapist driven protocol was feasible, safe, and useful for prescribing tailored training programs. Exercise prescriptions and training response differed among diseases.
DOI: 10.15468/erdspy
title: Scorpiofauna of Kashan (Esfahan Province, Iran) (Arachnida: Scorpiones)

description: This dataset contains the digitized treatments in Plazi based on the original journal article Vignoli, Valerio, Kovařík, František, Crucitti, Pierangelo (2003): Scorpiofauna of Kashan (Esfahan Province, Iran) (Arachnida: Scorpiones). Euscorpius 9: 1-7, DOI: 10.18590/euscorpius.2003.vol2003.iss9.1, URL: https://mds.marshall.edu/euscorpius/vol2003/iss9/1/
DOI: 10.5281/zenodo.5506712
title: Dataset related to article: "Laser photocoagulation therapy for thyroid nodules: long-term outcome and predictors of efficacy"

description: We provide the raw data used for the following article: Magri F, Chytiris S, Molteni M, Croce L, Coperchini F, Rotondi M, Fonte R, Chiovato L.<br> <em>Laser photocoagulation therapy for thyroid nodules: long-term outcome and predictors of efficacy.</em><br> "J Endocrinol Invest". 2020 Jan;43(1):95-100. doi: 10.1007/s40618-019-01085-8. Epub 2019 Jul 18. PMID: 31321758 <strong>Abstract</strong><br> <strong>Purpose: </strong> The aim of the present study was to retrospectively evaluate the efficacy of interstitial laser photocoagulation (ILP) ablation of thyroid nodules during a 6-year follow-up period and to identify possible predictors of the final outcome.<br> <strong>Methods: </strong> Forty-three outpatients (38 women) were assigned to ILP therapy. The study group included euthyroid patients with benign thyroid nodules. Thyroid size, nodule volume and features, and autoimmune test were collected at baseline. Patients underwent US control after the ILP procedure and 1 month, 6 months, 12 months later and then annually.<br> <strong>Results: </strong> During the follow-up, two distinct groups of patients emerged: the responders (N = 33) and the non-responder (N = 10) ones to ILP. In the responder group, the nodule volume significantly decreased during the follow-up, but a trend toward a slight increase in nodule volume was recorded up to the end of follow-up. No significant decrease in nodule volume was observed in the non-responder group. Neither baseline clinical nor demographic features were significantly different between responders and non-responders groups. In the whole group of patients, the energy delivered per mL of nodule tissue was significantly correlated with the percent volume decrease at the end of follow-up.<br> <strong>Conclusions: </strong> Interstitial laser photocoagulation is a safe technique able to reduce byabout 50% the volume of benign thyroid nodules in the majority of treated patients. However, due to the great variability of results, an active follow-up is required. The only independent predictor of ILP outcome is the energy delivered per mL of nodule tissue.
DOI: 10.5281/zenodo.5506711
title: Dataset related to article: "Laser photocoagulation therapy for thyroid nodules: long-term outcome and predictors of efficacy"

description: We provide the raw data used for the following article: Magri F, Chytiris S, Molteni M, Croce L, Coperchini F, Rotondi M, Fonte R, Chiovato L.<br> <em>Laser photocoagulation therapy for thyroid nodules: long-term outcome and predictors of efficacy.</em><br> "J Endocrinol Invest". 2020 Jan;43(1):95-100. doi: 10.1007/s40618-019-01085-8. Epub 2019 Jul 18. PMID: 31321758 <strong>Abstract</strong><br> <strong>Purpose: </strong> The aim of the present study was to retrospectively evaluate the efficacy of interstitial laser photocoagulation (ILP) ablation of thyroid nodules during a 6-year follow-up period and to identify possible predictors of the final outcome.<br> <strong>Methods: </strong> Forty-three outpatients (38 women) were assigned to ILP therapy. The study group included euthyroid patients with benign thyroid nodules. Thyroid size, nodule volume and features, and autoimmune test were collected at baseline. Patients underwent US control after the ILP procedure and 1 month, 6 months, 12 months later and then annually.<br> <strong>Results: </strong> During the follow-up, two distinct groups of patients emerged: the responders (N = 33) and the non-responder (N = 10) ones to ILP. In the responder group, the nodule volume significantly decreased during the follow-up, but a trend toward a slight increase in nodule volume was recorded up to the end of follow-up. No significant decrease in nodule volume was observed in the non-responder group. Neither baseline clinical nor demographic features were significantly different between responders and non-responders groups. In the whole group of patients, the energy delivered per mL of nodule tissue was significantly correlated with the percent volume decrease at the end of follow-up.<br> <strong>Conclusions: </strong> Interstitial laser photocoagulation is a safe technique able to reduce byabout 50% the volume of benign thyroid nodules in the majority of treated patients. However, due to the great variability of results, an active follow-up is required. The only independent predictor of ILP outcome is the energy delivered per mL of nodule tissue.
DOI: 10.6084/m9.figshare.16616995.v1
title: PRET1608S17F00_idba-ud_final.fna.gz

description: PRET1608S17F00_idba-ud_final.fna.gz
DOI: 10.6084/m9.figshare.16616995
title: PRET1608S17F00_idba-ud_final.fna.gz

description: PRET1608S17F00_idba-ud_final.fna.gz
DOI: 10.5281/zenodo.5483253
title: Dataset related to article: "Smart Flow for the evaluation of the hemodialysis arteriovenous fistula"

description: We provide the raw data used for the following article: Colucci M, Torreggiani M, Bernardi I, Stangalino S, Catucci D, Esposito V, Sileno G, Esposito C.<br> <em>Smart Flow for the evaluation of the hemodialysis arteriovenous fistula</em>. "J Vasc Access". 2020 Sep;21(5):652-657.<br> doi: 10.1177/1129729819897171. Epub 2020 Jan 2. PMID: 31894718. <br> <strong>Background: </strong>Smart Flow is an innovative tool available on the Carestream Touch Prime Ultrasound machines, which provides automated blood flow measurement and shows the vectors that form the blood flow in the vessel. We compared the use of Smart Flow with traditional Duplex Doppler Ultrasound to evaluate blood flow of arteriovenous fistulas in prevalent hemodialysis patients. <strong>Methods: </strong>A total of 31 chronic patients on hemodialysis were enrolled. Blood flow was measured on the brachial artery with Smart Flow and duplex Doppler ultrasound. In a subset of 26 patients, a video of the juxta-anastomotic efferent vein was recorded and analyzed to calculate an index of flow turbulence.<br> <strong>Results:</strong> We enrolled 21 males and 10 females aged 68.52±11.64 years at the time of evaluation with an average arteriovenous fistulas vintage of 50.23±47.42 months and followed them up for 18.03±5.18 months. Smart Flow and Duplex Doppler Ultrasound blood flow measurements positively correlated (p&lt;0.0001) in the same patient but Smart Flow gave higher blood flow values (995.0 vs 730.3mL/min, p&lt;0.0001), and the Duplex Doppler Ultrasound blood flow standard deviation was similar to Smart Flow (125.4 vs 114.4mL/min, p&lt;0.0001). The time needed to evaluate arteriovenous fistulas with Smart Flow was significantly shorter than Duplex Doppler Ultrasound (67.58±19.89 vs 146.3±26.35 s, p&lt;0.0001). No correlation was found between blood flow turbulence and the subsequent access failure.<br> <strong>Conclusion:</strong> Smart Flow is reliable, reproducible, and faster than traditional duplex ultrasound. However, the additional information given by the Smart Flow technique does not seem to add any further benefits in terms of prediction of the access failure
DOI: 10.5281/zenodo.5483252
title: Dataset related to article: "Smart Flow for the evaluation of the hemodialysis arteriovenous fistula"

description: We provide the raw data used for the following article: Colucci M, Torreggiani M, Bernardi I, Stangalino S, Catucci D, Esposito V, Sileno G, Esposito C.<br> <em>Smart Flow for the evaluation of the hemodialysis arteriovenous fistula</em>. "J Vasc Access". 2020 Sep;21(5):652-657.<br> doi: 10.1177/1129729819897171. Epub 2020 Jan 2. PMID: 31894718. <br> <strong>Background: </strong>Smart Flow is an innovative tool available on the Carestream Touch Prime Ultrasound machines, which provides automated blood flow measurement and shows the vectors that form the blood flow in the vessel. We compared the use of Smart Flow with traditional Duplex Doppler Ultrasound to evaluate blood flow of arteriovenous fistulas in prevalent hemodialysis patients. <strong>Methods: </strong>A total of 31 chronic patients on hemodialysis were enrolled. Blood flow was measured on the brachial artery with Smart Flow and duplex Doppler ultrasound. In a subset of 26 patients, a video of the juxta-anastomotic efferent vein was recorded and analyzed to calculate an index of flow turbulence.<br> <strong>Results:</strong> We enrolled 21 males and 10 females aged 68.52±11.64 years at the time of evaluation with an average arteriovenous fistulas vintage of 50.23±47.42 months and followed them up for 18.03±5.18 months. Smart Flow and Duplex Doppler Ultrasound blood flow measurements positively correlated (p&lt;0.0001) in the same patient but Smart Flow gave higher blood flow values (995.0 vs 730.3mL/min, p&lt;0.0001), and the Duplex Doppler Ultrasound blood flow standard deviation was similar to Smart Flow (125.4 vs 114.4mL/min, p&lt;0.0001). The time needed to evaluate arteriovenous fistulas with Smart Flow was significantly shorter than Duplex Doppler Ultrasound (67.58±19.89 vs 146.3±26.35 s, p&lt;0.0001). No correlation was found between blood flow turbulence and the subsequent access failure.<br> <strong>Conclusion:</strong> Smart Flow is reliable, reproducible, and faster than traditional duplex ultrasound. However, the additional information given by the Smart Flow technique does not seem to add any further benefits in terms of prediction of the access failure
DOI: 10.6084/m9.figshare.16617010
title: PRET1608S21F00_idba-ud_final.fna.gz

description: PRET1608S21F00_idba-ud_final.fna.gz
DOI: 10.6084/m9.figshare.16617010.v1
title: PRET1608S21F00_idba-ud_final.fna.gz

description: PRET1608S21F00_idba-ud_final.fna.gz
DOI: 10.6084/m9.figshare.16617013
title: PRET1608S25F00_idba-ud_final.fna.gz

description: PRET1608S25F00_idba-ud_final.fna.gz
DOI: 10.6084/m9.figshare.16617013.v1
title: PRET1608S25F00_idba-ud_final.fna.gz

description: PRET1608S25F00_idba-ud_final.fna.gz
DOI: 10.5281/zenodo.5507064
title: Preassembly of Gymnothorax fimbriatus (UNSM 395396)

description: Preassembly of Gymnothorax fimbriatus (UNSM 395396) based on SRA data (SRR14433904), derived using SPAdes 3.15.2. All contigs less than 200 bp removed.
DOI: 10.5281/zenodo.5507063
title: Preassembly of Gymnothorax fimbriatus (UNSM 395396)

description: Preassembly of Gymnothorax fimbriatus (UNSM 395396) based on SRA data (SRR14433904), derived using SPAdes 3.15.2. All contigs less than 200 bp removed.
DOI: 10.15468/ry4gs6
title: A note on the scorpions from the Pirin Mountains, south- western Bulgaria (Scorpiones: Buthidae, Euscorpiidae)

description: This dataset contains the digitized treatments in Plazi based on the original journal article Teruel, Rolando, Fet, Victor, de Armas, Luis F. (2004): A note on the scorpions from the Pirin Mountains, south- western Bulgaria (Scorpiones: Buthidae, Euscorpiidae). Euscorpius 14 (14): 1-11, DOI: 10.18590/euscorpius.2004.vol2004.iss14.1, URL: https://mds.marshall.edu/euscorpius/vol2004/iss14/1/
DOI: 10.5281/zenodo.5499713
title: Dataset related to article: "Diffuse idiopathic skeletal hyperostosis in subjects with congestive heart failure undergoing cardiac rehabilitation: A decision tree analysis"

description: We provide the raw data used for the following article: Ambrosino P, Scrutinio D, De Campi M, Miniero E, Formisano R, Spedicato GA, Iannuzzi GL, Pappone N.<br> <em>Diffuse idiopathic skeletal hyperostosis in subjects with congestive heart failure undergoing cardiac rehabilitation: A decision tree analysis. </em><br> "J Rehabil Med". 2020 Mar 18;52(3):jrm00030. doi: 10.2340/16501977-2658. PMID: 32104899. <strong>Abstract</strong> <strong>Objective: </strong> To assess the prevalence of diffuse idiopathic skeletal hyperostosis and its relationship with vascular risk factors among patients with congestive heart failure. <strong>Design: </strong> Population-based cross-sectional study. <strong>Participants: </strong> A total of 584 consecutive patients admitted to a Rehabilitative Cardiology Unit. <strong>Methods: </strong> Chi-square Automatic Interaction Detector (CHAID) decision tree analysis was used to build a predictive model. <strong>Results: </strong> The mean age (standard deviation) of the study population was 68.1 years (standard deviation 12.3), and 77.7% of the subjects were men. The overall prevalence of diffuse idiopathic skeletal hyperostosis in the cohort was 49.8%. Logistic regression analysis showed that age was a predictor of diffuse idiopathic skeletal hyperostosis (odds ratio: 1.034; 95% confidence interval 1.021-1.047, p &lt; 0.001), with increasing odds ratios for increasing age tertiles. The CHAID prediction model identified 2 age "buckets": &lt; 69 and ≥ 69 years. Patients ≥ 69 years had a diffuse idiopathic skeletal hyperostosis prevalence of 60.1%, compared with 39.2% among those &lt; 69 years. Notably, body mass index was a predictor of diffuse idiopathic skeletal hyperostosis in this younger subset of patients (p = 0.028), with 2 body mass index "buckets", ≤ 23.3 and &gt; 23.3 kg/m2, the latter showing more than twice the prevalence of diffuse idiopathic skeletal hyperostosis (43.2% vs 20%). <strong>Conclusion: </strong> Diffuse idiopathic skeletal hyperostosis is extremely frequent among patients with congestive heart failure, with age and body mass index being the strongest predictors.
DOI: 10.5281/zenodo.5499712
title: Dataset related to article: "Diffuse idiopathic skeletal hyperostosis in subjects with congestive heart failure undergoing cardiac rehabilitation: A decision tree analysis"

description: We provide the raw data used for the following article: Ambrosino P, Scrutinio D, De Campi M, Miniero E, Formisano R, Spedicato GA, Iannuzzi GL, Pappone N.<br> <em>Diffuse idiopathic skeletal hyperostosis in subjects with congestive heart failure undergoing cardiac rehabilitation: A decision tree analysis. </em><br> "J Rehabil Med". 2020 Mar 18;52(3):jrm00030. doi: 10.2340/16501977-2658. PMID: 32104899. <strong>Abstract</strong> <strong>Objective: </strong> To assess the prevalence of diffuse idiopathic skeletal hyperostosis and its relationship with vascular risk factors among patients with congestive heart failure. <strong>Design: </strong> Population-based cross-sectional study. <strong>Participants: </strong> A total of 584 consecutive patients admitted to a Rehabilitative Cardiology Unit. <strong>Methods: </strong> Chi-square Automatic Interaction Detector (CHAID) decision tree analysis was used to build a predictive model. <strong>Results: </strong> The mean age (standard deviation) of the study population was 68.1 years (standard deviation 12.3), and 77.7% of the subjects were men. The overall prevalence of diffuse idiopathic skeletal hyperostosis in the cohort was 49.8%. Logistic regression analysis showed that age was a predictor of diffuse idiopathic skeletal hyperostosis (odds ratio: 1.034; 95% confidence interval 1.021-1.047, p &lt; 0.001), with increasing odds ratios for increasing age tertiles. The CHAID prediction model identified 2 age "buckets": &lt; 69 and ≥ 69 years. Patients ≥ 69 years had a diffuse idiopathic skeletal hyperostosis prevalence of 60.1%, compared with 39.2% among those &lt; 69 years. Notably, body mass index was a predictor of diffuse idiopathic skeletal hyperostosis in this younger subset of patients (p = 0.028), with 2 body mass index "buckets", ≤ 23.3 and &gt; 23.3 kg/m2, the latter showing more than twice the prevalence of diffuse idiopathic skeletal hyperostosis (43.2% vs 20%). <strong>Conclusion: </strong> Diffuse idiopathic skeletal hyperostosis is extremely frequent among patients with congestive heart failure, with age and body mass index being the strongest predictors.